{"abstract": "The transaction would be the latest in an acquisition spree by Shire since its tentative agreement to be bought by the drug maker AbbVie was terminated.", "web_url": "https://www.nytimes.com/2015/11/03/business/dealbook/shire-dyax-corp-deal.html", "snippet": "The transaction would be the latest in an acquisition spree by Shire since its tentative agreement to be bought by the drug maker AbbVie was terminated.", "lead_paragraph": "LONDON \u2014 The Irish drug maker Shire said on Monday that it had agreed to acquire the American biotechnology company Dyax Corporation in a deal that could be worth as much as $6.5 billion.", "print_section": "B", "print_page": "11", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-articleLarge.jpg", "height": 400, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2015/11/03/business/db-shire-web1/db-shire-web1-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 400}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-jumbo.jpg", "height": 683, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-superJumbo.jpg", "height": 1366, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbStandard.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbStandard.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2015/11/03/business/db-shire-web1/db-shire-web1-thumbLarge.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "Irish Drug Maker Shire Agrees to Buy Dyax in Deal Worth Up to $6.5 Billion", "kicker": null, "content_kicker": null, "print_headline": "Irish Drug Maker Shire Agrees to Buy Dyax in Deal Worth Up to $6.5 Billion", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "persons", "value": "Bray, Chad", "rank": 1, "major": "N"}, {"name": "organizations", "value": "Dyax Corporation", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Shire PLC", "rank": 3, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 4, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 5, "major": "N"}, {"name": "organizations", "value": "Food and Drug Administration", "rank": 6, "major": "N"}, {"name": "organizations", "value": "AbbVie Inc", "rank": 7, "major": "N"}, {"name": "organizations", "value": "Baxter International", "rank": 8, "major": "N"}, {"name": "organizations", "value": "NPS Pharmaceuticals Inc", "rank": 9, "major": "N"}, {"name": "organizations", "value": "Salix Pharmaceuticals Ltd", "rank": 10, "major": "N"}], "pub_date": "2015-11-02T13:54:11+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By Chad Bray", "person": [{"firstname": "Chad", "middlename": null, "lastname": "Bray", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/6ab5f1e2-ec04-5e3e-a10e-b9b43cdf3514", "word_count": 455, "uri": "nyt://article/6ab5f1e2-ec04-5e3e-a10e-b9b43cdf3514"}